Beijing Bohui Innovation Biotechnology Group Co., Ltd. (SHE:300318)

China flag China · Delayed Price · Currency is CNY
6.50
-0.17 (-2.55%)
Jan 23, 2026, 3:12 PM CST
18.18%
Market Cap5.31B
Revenue (ttm)834.38M
Net Income (ttm)-48.09M
Shares Out816.90M
EPS (ttm)-0.06
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume23,473,204
Average Volume16,504,325
Open6.67
Previous Close6.67
Day's Range6.31 - 6.67
52-Week Range5.29 - 8.63
Beta-0.19
RSI53.84
Earnings DateApr 25, 2026

About SHE:300318

Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China. The company offers human immunoglobulin for rabies, tetanus, hepatitis B, and intravenous injections; albumin; human prothrombin complex; and vaccine for rabies. It also provides molecular platform, such as Automatic Real-time Fluorescent Nucleic Acid Cartridge Analyzer(BHQ-III), and GenPlex BHF-VI Nucleic Acid Chip Analyzer; Trace Element Analyzers; Fluorescence Immunoassay An... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 2,179
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300318
Full Company Profile

Financial Performance

Financial Statements